The mi locus of mice encodes a member of the basic-helixloop-helix-leucine zipper (bHLH-Zip) protein family of transcription factors (hereafter called MITF). Cultured mast cells of mi/mi genotype (mi/mi CMCs) did not normally respond t o stem cell factor (SCF), a ligand for the c-kit receptor tyrosine kinase. The poor response of mi/mi CMCs t o SCF was attributed t o t h e defrcient expression of c-kit in both the mRNA and protein levels. The purpose of the present study is to investigate the effect of MlTF on the transcription of the c-kit gene. First, we introduced cDNA encoding normal (+) MlTF or mutant (mi) MITF into mi/mi CMCs using the retroviral vector. Overexpression of +-MITF but not mCMITF normalized the expression of the c-kit and the poor response of mi/miCMCs t o SCF, indicating the involvement af +-MITF in the c-kit gene transactivation. Second, we analyzed the promoter of the c-kit gene. Three CANNTG motifs recognized by bHLH-Zip-type transcription factors were conserved between the mouse and human c-kit promoters. Among HE mi LOCUS OF MICE on chromosome 6 encodes a member of the basic-helix-loop-helix leucine zipper (bHLH-Zip) protein family of transcription factors (hereafter called MITF).1.2 More than 10 mutants at the mi locus are known, and half of them have been characterized at the molecular The mutant mi allele encodes MITF carrying the deletion of 1 of 4 consecutive arginine residues in the basic d~m a i n . "~ Mutant mice of rni/tni genotype exhibit microphthalmia, depletion of pigment in both hair and eyes, and osteopetro~is.~.~ In addition, depletion of mast cells has been reported in mi/mi mice?-9
The mi locus of mice encodes a member of the basic-helixloop-helix-leucine zipper (bHLH-Zip) protein family of transcription factors (hereafter called MITF). Cultured mast cells of mi/mi genotype (mi/mi CMCs) did not normally respond t o stem cell factor (SCF), a ligand for the c-kit receptor tyrosine kinase. The poor response of mi/mi CMCs t o SCF was attributed t o t h e defrcient expression of c-kit in both the mRNA and protein levels. The purpose of the present study is to investigate the effect of MlTF on the transcription of the c-kit gene. First, we introduced cDNA encoding normal (+) MlTF or mutant (mi) MITF into mi/mi CMCs using the retroviral vector. Overexpression of +-MITF but not mCMITF normalized the expression of the c-kit and the poor response of mi/miCMCs t o SCF, indicating the involvement af +-MITF in the c-kit gene transactivation. Second, we analyzed the promoter of the c-kit gene. Three CANNTG motifs recognized by bHLH-Zip-type transcription factors were conserved between the mouse and human c-kit promoters. Among HE mi LOCUS OF MICE on chromosome 6 encodes a member of the basic-helix-loop-helix leucine zipper (bHLH-Zip) protein family of transcription factors (hereafter called MITF).1.2 More than 10 mutants at the mi locus are known, and half of them have been characterized at the molecular The mutant mi allele encodes MITF carrying the deletion of 1 of 4 consecutive arginine residues in the basic d~m a i n . "~ Mutant mice of rni/tni genotype exhibit microphthalmia, depletion of pigment in both hair and eyes, and osteopetro~is.~.~ In addition, depletion of mast cells has been reported in mi/mi mice? -9 Despite mast cell deficiency in mi/mi mice, mast cells developed when spleen cells of mi/mi mice were cultured in the presence of T-cell-derived growth factors.' The proliferative response of cultured mast cells derived from mi/mi mice (mi/mi CMCs) to interleukin-3 (IL-3) was comparable to that of normal (+/+) CMCs, but mi/mi CMCs did not respond normally to stem cell factor (SCF), the ligand for the c-kit receptor tyrosine kinase." The poor response of mi/ mi CMCs to SCF was attributed to the reduced expression of c-kit at both the mRNA and protein levels." The expression of c-kit was also deficient in the skin of mi/mi mice." In contrast, c-kit is normally expressed by erythroid precursors, testicular germ cells, and some types of neurons of mi/mi mice." These results suggest that MITF is indispensable for transcription of the c-kit gene in mast cells, but not in erythroid precursors, testicular germ cells, and neurons.
Transcription factors of the bHLH-Zip protein family, including MITF, recognize a consensus sequence of CANNTG motif (any nucleotides are compatible with position N). 12 We have recently shown the binding of the normal MITF (hereafter called +-MITF) to a CACATG motif in the 5' flanking region of the mouse mast cell protease (MMCP)-6 gene,13 whose expression was greatly reduced in both mi/mi CMCs and mVmi skin mast ~e 1 l s . l~~'~ We also showed the loss of DNA binding ability of the mutant MITF encoded by the mi mutant allele (hereafter called mi-MITF).I3 In the present study, we have examined whether MITF might be involved in the transactivation of c-kit gene expression in these three CANNTG motifs, only the CACCTG motif (nt -356 t o -351) was specifically bound by +-MITF. When the luciferase gene under the control of the c-kit promoter was cotransfected into NIH/3T3 fibroblasts with cDNA encoding +-MITF or mi-MITF, the luciferase activity significantly increased only when +-MITF cDNA was cotransfected. The deletion of the promoter region containing the CACCTG motif or the mutation of the CACCTG t o CTCCAG abolished the transactivation effect of +-MITF, indicating that +-MITF transactivated the c-kit gene through the CACCTG motif. When the luciferase gene under the control of the c-kit promoter was introduced into the FMAB mastocytoma and FDC-P1 myeloid cell lines, remarkable luciferase activity was observed only in FMAB cells. Thus, the involvement of +-MITF in the c-kit transactivation appeared t o be specific to the mast cell lineage. mast cells. We introduced +-MITF cDNA into mi/mi CMCs and found that the overexpression of +-MITF but not mi-MITF normalized c-kit transcription and the poor response of mi/mi CMCs to SCF. Moreover, we showed that the interaction between the +-MITF and the CACCTG motif in the 5' flanking region of the c-kit gene mediated the transactivation effect and that the involvement of +-MITF in the c-kit expression was specific to the mast cell lineage.
MATERIALS AND METHODS

Mice.
The original stock of C57BL/6-mi/+ (mi/+) mice was purchased from the Jackson Laboratory (Bar Harbor, ME) and was maintained in our laboratory by consecutive backcrosses to our own inbred C57BL16 colony (more than 12 generations at the time of the present experiment). Female mi/+ mice were crossed with male mi/+ mice, and the resulting mi/mi mice were selected by their white coat Cells. Pokeweed mitogen-stimulated spleen cell conditioned medium (PWM-SCM) was prepared according to the method described by Nakahata et Mice of mumi genotype and their normal (+I+) littermates were used at 2 to 3 weeks of age to obtain CMCs. Mice were killed by decapitation after ether anesthesia and spleens
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TSUJIMURA ET AL were removed. Spleen cells derived from m i h i or +/+ mice were cultured with a-minimal essential medium (a-MEM; ICN Biomedicals, Costa Mesa, CA) supplemented with 10% PWM-SCM and 10% fetal calf serum (FCS; Nippon Bio-Supp Center, Tokyo, Japan). Half of the medium was replaced every 7 days, and more than 95% of cells were CMCs 4 weeks after the initiation of the culture.16 The helper virus-free packaging cell line (92)'' was maintained in Dulbecco's modification of Eagle's medium (DMEM; ICN Biomedicals) supplemented with 10% FCS. The NIW3T3 fibroblast cell line was generously provided by Dr S.A. Aaronson (National Cancer Institute, Bethesda, MD) and maintained in DMEM supplemented with 10% FCS. The FMA3 mouse mastocytoma cell line'" was generously given by Dr H. Hasegawa (The Nishi-Tokyo University, Yamanashi, Japan). FMA3 cells were adapted to grow in a-MEM supplemented with 10% FCS. The FDC-PI mouse IL-3-dependent myeloid cell line" was maintained in a-MEM supplemented with 10% PWM-SCM and 10% FCS.
Construction of retrovirus vector and its infection. Bluescript KS (-) plasmids (pBS; Stratagene, La Jolla, CA) containing the whole coding regions of +-MITF or mi-MITF (pBS-+-MITF and pBS-mi-MITF, respectively) had been constructed in our laboratory." A retroviral vector pM5Gneo,2" a derivative of myeloproliferative sarcoma virus vector, was a kind gift of Dr W. Ostertag (Universitat Hamburg, Hamburg, Germany). The purified Sma I-HincII fragment from pBS-+-MITF or pBS-mi-MITF was introduced into the blunted EcoRI site of pM5Gneo. The resulting pM5Gneo-+-MITF and pMSGneo-mi-MITF were transfected into the packaging cell line (92) by the calcium phosphate method," and neomycinresistant 9 2 cell clones were selected by culturing in DMEM supplemented with 10% FCS and G418 (0.8 mg/mL; GlBCO BRL, Grand Island, NY). For gene transfer, either spleen cells obtained from mi/ mi mice or FDC-P1 cells were incubated on irradiated (30 C y ) subconfluent monolayer of virus-producing $2 cells for 72 hours in a-MEM supplemented with 10% PWM-SCM and 10% FCS. Neomycin-resistant CMCs or FDC-P1 cells were obtained by continuing the culture in a-MEM containing 10% PWM-SCM, IO% FCS, and G418 (0.8 mg/mL) for 4 weeks.
Northern blotting analysis. Total RNAs of cells were prepared by lithium chloride-urea method,** and poly(A)+ RNAs were purified by Oligotex-dT30 (Japan Synthetic RubberNippon Roche, Tokyo, Japan). The fragments of mouse +-MITF (nucleotide [nt] 433 to Il76).' and 0-actid4 cDNAs were used as probes after being labeled with a-['*P]-deoxycytidine triphosphate (dCTP; DuPont/ NEN Research Products, Boston, MA: IO mCi/mL) by random oligonucleotide priming. After hybridization at 42°C blots were washed to a final stringency of 0.2X SSC (IX SSC is 150 mmol/L NaCl and 15 mmol/L trisodium citrate, pH 7.4) at 50°C and subjected to autoradiography.
Immunocytochemistry by anti-MITF antibody. A rabbit anti-MITF antibody was prepared in our lab~ratory.*~ Immunocytochemistry was performed as described by Takebayashi et with a minor modification. Briefly, cells were cytocentrifuged and fixed with 4% paraformaldehyde for 30 minutes at 4°C. After microwave treatment (H2500 Microwave Processor; Bio-Rad Laboratories, Hercules, CA) in 0.01 molL citrate buffer (pH 6.0) for 3 minutes, specimens were stained with the rabbit anti-MITF antibody."
Flow cytometry. Cells were incubated first with rat antimouse ckit (ACK2) monoclonal antibody (MoAb), a gift of Dr S.I. Nishikawa (Kyoto University, Kyoto, Japan) at 4°C for 30 minutes, rinsed, and then stained with fluorescein isothiocyanate-conjugated rabbit antirat Ig antibody (DAKO A / S , Glostrup, Denmark). Cells were rinsed and analyzed on a FACScan (Becton Dickinson, Los Angeles, CA).
[ZH]-thymidine incorporation. Proliferation of CMCs was quantified by ['HI-thymidine incorporation as previously described." The exponentially growing cells were washed twice with a-MEM, and triplicate aliquots of cells (5 X IO4) suspended in 200 pL of Cosmedium-001 (Cosmo Bio CO, Tokyo. Japan) were cultured in 96-well microtiter plates for 48 hours at 37°C with various concentrations of recombinant mouse IL-3 (rmIL- 3) or rmSCF. rmIL-3 and rmSCF were generous gifts of Kirin Brewery CO Ltd (Tokyo, Japan). At 48 hours after initiation of the culture, 0.5 pCi ['HI-thymidine (specific activity, 5 Ci/mmol; Amersham, Arlington Heights, 1L) was added to each well. Five hours after the addition of ['Hi-thymidine, the cells were harvested with a semiautomatic cell harvester (Pharmacia LKB Biotechnology, Uppsala, Sweden) and the incorporation of ['HI-thymidine was measured with a liquid scintillation counter. Three independent experiments were performed.
1.solation of genomic clones and sequencing. The hEMBL3 genomic library prepared from a partial Sau3A digest of 129/Sv strain m o u~e liver DNA was used for ~creening.~' The 272-bp Sac I-RamHI fragment representing the 5' sequence of the c-kit cDNA was prepared from the full-length c-kit cDNA kindly provided by Dr S.I. Nishikawa (Kyoto University). In total, 8 X 10' clones were screened by plaque hybridization using the Sac I-BamHI fragment of c-kif cDNA labeled with a-["PJ-dCTP as a probe. DNAs of positive clones were purified after three sequential rounds of screening. Inserts were subcloned into the plasmid pUC19 for further analysis. Nucleotide sequence was determined by Model 373A DNA sequencer (Applied Biosystems, Foster City, CA) using Taq dye deoxyterminator cycles sequencing kit (Applied Biosystems).'x Electrophoretic gel mobility shifi assay (EGMSAJ. The production and purification of glutathione-S-transferase (GST)-+-MITF and GST-mi-MITF fusion proteins were described previously.'' Oligonucleotides were labeled with a-['*P]-dCTP by tilling S'-overhangs and used as probes of EGMSA. DNA-binding assays were performed in a 20 pL reaction mixture containing I O mmol/L Tris-HCI (pH 8.0), l mmol/L EDTA, 75 mmol/L KCI, I mmol/L dithiothreitol, 4% Ficoll type 400, 50 ng of poly (dI-dC), 25 ng of the labeled DNA probe, and 3.5 mg of GST-+-MITF or GST-mi-MITF fusion proteins. After the incubation at room temperature for 15 minutes, the reaction mixture was subjected to electrophoresis at 14 V/cm at 4°C on a 5 8 polyacrylamide gel in 0.25X TBE buffer ( I X TBE is 90 mmol/L Tris-HCI, 64.6 mmol/L boric acid, and 2.5 mmol/ L EDTA, pH 8.3). The polyacrylamide gels were dried on Whatman 3MM chromatography paper (Whatman, Maidstone, UK) and subjected to autoradiography. Competitive DNA-binding assays were performed as described above, except that the unlabeled competitive DNA was added to the reaction mixture before the addition o f GST-+-MITF fusion proteins.
Construction vf eflector and reporter plasmids. pEF-BOS expression vector'y was kindly provided by Dr S. Nagata (Osaka Bioscience Institute, Osaka, Japan). The Sma I-Hind1 fragment of pBS-+-MITF or pBS-mi-MITF was introduced into the blunted Xba I site of pEF-BOS. The resulting pEF-+-MITF and pEF-mi-MITF expression vectors were used as effectors. The luciferase gene subcloned into pSP72 (pSPLuc)"' was generously provided by Dr K. Nakajima (Osaka University Medical School, Osaka, Japan). TO construct reporter plasmids, a 655-bp (nt -622 to +33, + I shows transcription initiation site)" Pvu 11-Sac I or a 251-bp (nt -21 8 to +33) BarnHI-Sac 1 fragment of the c-kit gene was introduced into upstream of the luciferase gene in pSPLuc.
Transient coexpression assay. NIH/3T3 (5 X IO5) cells were plated in a 10-cm dish I day before the procedure. Cotransfection with 10 pg of a reporter, 100 ng of an effector, and 2 p g of an expression vector containing the &galactosidase gene was performed by the calcium phosphate precipitation method." The expression vector containing the 0-galactosidase gene was used as an internal control. The cells were harvested 48 hours after the transfection and lysed with 0.1 moVL potassium phosphate buffer (pH 7.4) containing 1% Triton X-100. Extracts were then used to assay the luciferase activity with a luminometer LB96P (Berthold GmbH. Wildbad, Germany) and the P-galactosidase activity. The luciferase acFor personal use only. on November 16, 2017 . by guest www.bloodjournal.org From mi TRANSCRIPTION FACTOR tivity was normalized by the 8-galactosidase activity and total protein concentration according to the method described by Yasumoto et al." The normalized value was divided by the value obtained from the cotransfection with a reporter and pEF-BOS and was expressed as the relative luciferase activity.
Transfection of luciferase gene into hematopoietic cell lines. Reporter plasmids, a 655-bp (nt -622 to +33) PIJN 11-Sac I fragment containing either the CACCTG motif or the mutation at the CAC-CTG motif (to CTCCAG). were digested with Sca 1. The linearized plasmids ( 1 0 0 pg) and pSTneoB ( I pg) were added to cell suspension ( I X 10') in 0.7 mL phosphate-buffered saline (PBS), mixed gently, and incubated on ice for 10 minutes. For gene transfer, FMA3 and FDC-PI cells were electroporated by a single pulse (975 pF, 350 V) from Gene Pulser I1 (Bio-Rad Laboratories). After incubation on ice for 10 minutes, the cells were suspended in 10 mL complete culture medium. Two days after the electroporation, 800 pglmL of G41 8 was added to the complete culture medium to select neomycinresistant cells. When neomycin-resistant cells proliferated, the cells ( I X 10') were harvested and lysed with 0.1 moln potassium phosphate buffer (pH 7.4) containing 1 8 Triton X-100. Extracts were then used to assay the luciferase activity with a luminometer LB96P.
Rever (Fig 1A) . To know the proportion of CMCs that were infected with the retrovirus, we stained various CMCs with the anti-MITF antibody. Although intact +/+ and m i h i CMCs were not stained with the antibody due to the low content of +-MITF or mi-MITF, practically all mi/ mi CMCs treated with the retrovirus containing either +-MITF or mi-MITF cDNA were stained with the antibody (data not shown).
Overexpression of +-MITF in mi/mi CMCs resulted in the normalization of both c-kit mRNA and protein expression (Fig 1A and B) . CMCs, and the overexpression of +-MITF did not affect the proliferative response of rni/rni CMCs to rmlL-3 (Fig 2A) .
For In contrast, the overexpression of +-MITF but not mi-MITF normalized the poor response of m i h i CMCs to rmSCF ( Fig  2B) .
Sequencing of S' junking region of c-kit. A mouse genomic DNA library was screened for clones containing the 5' flanking region of the c-kit gene by using the Sac I-BamHI fragment of c-kit cDNA. Two overlapping clones (KIT-l0 and KIT-12) that hybridized to the c-kit exon 1 and four overlapping clones (KIT-13, KIT-14, , and KIT-l 8) CANNTG motifs, the surrounding sequence of the CACCTG and CAGGTG motifs (nt -374 to -334) and that of the CACTTG motif (nt -32 to + 18) were highly conserved between the human and mouse c-kit genes (93% and 98%'. respectively).
Binding qf MITF. EGMSA was performed with each oligonucleotide probe containing the CANNTG motif(s) to examine whether +-MITF practically bound the CANNTG motif(s) in the c-kit promoter. The S'-AGGGAGCCACCT--GCCAGGTGGCTGGC oligonucleotide containing two hexameric motifs (probe 1 ; the hexameric motifs are shown by the underlines) and the S'-GCTCGGTGCACTTGGGCG-AGAGC oligonucleotide containing a hexameric motif (probe 2) were synthesized and labeled. EGMSA was performed using GST-+-MITF or GST-mi-MITF fusion protein and each probe (Fig 4) . No retarded band was observed in the sample that contained no proteins (probe only; data not shown). A retarded band was observed in the sample containing the probe 1 and GST-+-MITF but not in the sample containing the probe 1 and GST-mi-MITF (Fig 4) . In contrast to the probe I , the probe 2 was bound by neither GST-+-MITF nor GST-mi-MITF (Fig 4) .
To examine the specificity of the binding of the GST-+-MITF to probe 1, we added unlabeled oligonucleotide 1 that had the identical sequence with probe 1 (oligo 1; Fig 5A) to the reaction mixture containing the GST-+-MITF and probe 1. The binding of the GST-+-MITF to probe 1 was completely inhibited (Fig 5B) . We then performed competition binding with oligonucleotide 5 in which both hexameric motifs in the probe 1 were mutated (oligo 5 of Fig 5A) . The addition of unlabeled oligo 5 did not affect the binding of GST-+-MITF to probe 1 (Fig SB) . Because probe I contained two hexameric motifs, we investigated which hexameric motif was necessary for the binding of the GST+-MITF. Two probes were synthesized and labeled; the CAGGTG motif was mutated to CTGGAG in the probe 3, and the CACCTG motif was mutated to CTCCAG in the probe 4 ( Fig SA) . In the lane containing the GST-+-MITF fusion protein and the probe 3, a retarded band was observed ( Fig  SB) . To examine the specificity of binding, we added unlabeled oligonucleotide 3 that had the identical sequence with the probe 3 (oligo 3 of Fig SA) to the reaction mixture containing the GST-+-MITF and the probe 3. The binding of the GST-+-MITF to the probe 3 was completely inhibited (Fig 5B) . In contrast, the addition of the unlabeled oligo S did not inhibit the binding of the GST-+-MITF to the probe c t g a g g t c a g g g g t g a c g a t c c g t c c t c c t c t a a g g g g a a g a a g c g a g a c c c g g g c g g g c g c g a g g g a g g g g t -g 
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sac I 3 (Fig 5B) . No retarded band was detectable in the lane containing the GST-+-MITF fusion protein and the probe 4 (Fig 5B) . Taken together, although there were three conserved CANNTG motifs (CACCTG, CAGGTG, and CAC-TTG motifs) in 5' flanking region of the c-kit, +-MITF bound only the CACCTG motif. Transactivation effect of MITF on the c-kit promoter. We performed the transient coexpression assay to examine whether the CACCTG motif of the c-kit 5' flanking region mediated the transactivation ability of MITF. The promoter region and the first exon of c-kit gene (nt -622 to +33) was cloned upstream from the luciferase gene. The cDNA encoding +-MITF or mi-MITF was cotransfected into NIW 3T3 fibroblasts with the luciferase gene under the control of the intact c-kit promoter containing the CACCTG motif. The coexpression of +-MITF but not mi-MITF significantly increased the luciferase activity (Fig 6) . A part of the promoter containing the CACCTG motif (nt -622 to -219) was then deleted. The deletion abolished the transactivation ability of +-MITF (Fig 6) . Moreover, the mutation of the CACCTG motif to CTCCAG also abolished the transactivation ability of + -M m (Fig 6) .
Specificity of mast cell lineage. We examined whether the transactivation of the c-kit gene induced by the +-MITF was specific to the mast cell lineage. Although mast cells proliferate even after the morphological differentiation, hematopoietic cells belonging to other lineages die after the differentiati~n.~~ Therefore, we used the FDC-P1 myeloid cell line instead of primary myeloid cell cultures. As a control, the FMA3 mastocytoma cell line was used. We introduced the luciferase gene under the control of the c-kit promoter containing the CACCTG motif into FMA3 and FDC-P1 cells with electroporation. The luciferase activity was significantly higher in FMA3 cells than in FDC-P1 cells ( Fig 7A) . The mutation at the CACCTG motif to CTCCAG in the c-kif promoter abolished the luciferase activity in FMA3 cells (Fig 7A) .
There is a possibility that FDC-PI cells did not express the +-MITF. The expression of +-MITF mRNA in FMA3 The W'" is a mutant allele at the W (c-kit) locus of mice.' but no significant abnormalities were found within the c-kit coding region of the W'" allele.'" The W'" mutation is sup- The magnitude of the mast cell deficiency was more severe in W"/Wh mice than in mumi mice.9s3h The number of mast cells in the skin correlates with the magnitude of c-kit gene expression. Undetectable c-kit transcripts were observed in W h W h CMCs even by using RT-PCR.3h On the other hand, a weak but apparent band representing the c-kit mRNA was detectable by Northern blot analysis of mUmi CMCs (Fig 1) . Recently, the molecular legion associated with the W" allele was roughly ider~tified.~' The W" mutant allele possesses an inversion of a small segment of chromosome 5 , whose break points lay very far from the c-kit coding region." However, the mechanism of defective c-kit expression as a result of the W" mutation has not been examined in detail, and it is not clear whether MITF is involved.
Hematopoietic stem cells also express kit."^'^ When stem cells differentiate into mast cells, the expression of ckit appears to increa~e.~' Even mature mast cells strongly express c-kit on the ~u r f a c e .~' ,~~ On the other hand, c-kit expression appears to decrease when stem cells differentiate into cell lineages other than mast cell^."^^^^^' We introduced the luciferase gene under the control of the c-kit promoter into the FMA3 mastocytoma and FDC-PI myeloid cell lines to examine whether the transactivation of the c-kit gene induced by the +-MITF was specific to the mast cell lineage. Although the +-MITF was apparently expressed not only in FMA3 but also in FDC-P1 cells, the luciferase activity was much greater in FMA3 cells than in FDC-P1 cells. Moreover, even if the +-MITF was overexpressed in FDC-P1 cells, the expression of c-kit was hardly detectable. These results suggested that the involvement of the +-MITF in the transcription of the c-kit gene was specific to the mast cell lineage. The regulation of c-kit expression may be different between the mast cell lineage and other blood cell lineages. We speculate that MITF may play a role in regulating c-kit expression when stem cells differentiate into the mast cell lineage.
Taken together, the present results have shown an essential role of MITF in the expression of the c-kit gene in mast cells. MITF appears to transactivate the c-kit gene through the CACCTG motif in the c-kit promoter. sion. 36.37 
